Drug interactions
Abiraterone + Liposomal doxorubicin
Severity: Minor
Abiraterone and Liposomal doxorubicin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Abiraterone inhibits CYP2D6, and doxorubicin is partly a CYP2D6 substrate in vitro, but this is not a major elimination route.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Abiraterone and Liposomal doxorubicin interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Abiraterone
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
